PREMALIGNANT LESION

Clinical trials for PREMALIGNANT LESION explained in plain language.

Never miss a new study

Get alerted when new PREMALIGNANT LESION trials appear

Sign up with your email to follow new studies for PREMALIGNANT LESION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 3

Could a shot stop mouth cancer before it starts?

Disease control Recruiting now

This study tests if injecting the cancer drug nivolumab directly into high-risk precancerous mouth lesions can stop them from turning into cancer. About 45 adults with these lesions will receive either the drug or a placebo injection. The goal is to see if the treatment is safe a…

Matched conditions: PREMALIGNANT LESION

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Jun 15, 2026 19:02 UTC

PREMALIGNANT LESION

Get alerted when new PREMALIGNANT LESION trials appear

Could a shot stop mouth cancer before it starts?